Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
96,932,157
-
Share change
-
-864,095
-
Total reported value
-
$2,899,646,438
-
Put/Call ratio
-
138%
-
Price per share
-
$29.93
-
Number of holders
-
208
-
Value change
-
-$27,965,739
-
Number of buys
-
119
-
Number of sells
-
94
Institutional Holders of NPS PHARMACEUTICALS INC - COM (P103PS) as of Q1 2014
As of 31 Mar 2014,
NPS PHARMACEUTICALS INC - COM (P103PS) was held by
208 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,932,157 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT CO LLP, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLS FARGO & COMPANY/MN, OAK RIDGE INVESTMENTS LLC, COLUMBIA WANGER ASSET MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., and ALLIANCEBERNSTEIN L.P..
This page lists
208
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.